Integumen subsidiary Labskin teams up with University of Aberdeen in coronavirus fight

The plan is to test anti-viral skin and dental products that might mitigate the transmission risk of the infection

Integumen -

Integumen PLC (LON:SKIN) said its subsidiary Labskin has partnered with the University of Aberdeen to test anti-viral skin and dental products that might mitigate the transmission risk of the coronavirus (COVID-19).

Scientists will use Labskin’s cloned human skin coated with the SARS-CoV-2 virus in their research, which will take place in a Category 3 lab at the university. Work will be carried out to assess the transferability of viral particles from materials to skin.

Also being studied is the ability of the virus to remain infective while on the skin surface. Ultimately, the team hopes to quantify the efficacy of mouthwash and dental care products as well as soap washing and hand sanitisers.

"COVID-19 has had such a dramatic impact on lives across world, it is important to find products that can help to mitigate the risk of infection, particularly, in professional settings,” Integumen chief executive, Gerard Brandon said in a statement.

“Labskin is in a unique position to aid the fight against COVID-19 and with the support of the University of Aberdeen, can facilitate testing of the COVID-19 virus on our cloned human skin."

He added: “We will study the effects of a variety of products and ingredients in the university's secure containment Level 3 laboratory environment without exposing human volunteers to dangerous and challenging clinical trial contamination risk. 

“The more knowledge we have about SARS-CoV-2 - how it spreads, and more importantly, how to contain that spread - the better equipped to fight this virus we will be."

Quick facts: Integumen

Price: 1.9 GBX

Market: AIM
Market Cap: £20.5 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...



Morning Report: FTSE 100 nervous, gold higher as second wave concerns resurface

Headlines from the Proactive UK newsroom. FTSE 100 dipped as the rise in coronavirus infections in Germany and China unsettled the market. The index dropped 25 to 6,266. Gold rose to a one month high of US$1,750 per ounce overnight as Asian markets wobbled on the coronavirus scare. Bulls of...

2 weeks, 4 days ago

2 min read